期刊文献+

上海社区高血压疾病细节管理对高血压患者血压和血脂的影响研究 被引量:15

Effects of Disease Details Management Program for Hypertension on Blood Pressure and Serum Lipid of Hypertensive Patients in Shanghai Community
下载PDF
导出
摘要 目的评价社区高血压疾病细节管理对高血压患者血压和血脂控制的效果。方法资料来自上海市区4个社区的现场调查,共招募1 442例符合心血管危险分层属于中危层或高危层的原发性高血压病患者,其中男性占36.27%,女性占63.73%;中危层患者占82.39%,高危层患者占17.61%。采用自动生化分析仪测定血清三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-c)和低密度脂蛋白胆固醇(LDL-c)水平。非药物干预包括加强社区医生和高血压患者间的沟通,通过讲座和资料发放传播高血压防治知识和技能。结果与日常管理组比较,干预后细节管理组的收缩压和舒张压净下降6.75 mm Hg和4.29 mm Hg(P<0.001);血清TG和TC明显下降(t=4.249,P<0.001;t=2.231,P=0.026);血清HDL-c和LDL-c没有明显变化(P>0.05)。结论社区高血压疾病细节管理不但可以降低高血压患者的血压水平,而且有助于血脂的改善,特别是TG和TC水平。 Objective To evaluate the effectiveness of disease details management program on control of blood pressure and blood lipid for hypertensive patients in communities. Methods Totally 1 442 primary hypertension patients(males accounting for 36.27% and females for 63.73%) who,according to risk stratification,belong to moderate-risk(accounting for 82.39%) and high-risk(accounting for 17.61%) from 4 communities in Shanghai were enrolled.The serum levels of triglyceride(TG),total cholesterol(TC),high density lipoprotein cholesterol(HDL-c),and low density lipoprotein cholesterol(LDL-c) were measured by automatic biochemical analyzer.Non-pharmacological intervention included enhancing communication between community physicians and patients,and population of knowledge and skills of hypertension control through lectures and materials on health. Results Comparing with the conventional group,in the details management group the net decreases of systolic and diastolic blood pressure were 6.75 and 4.29 mm Hg respectively after the intervention(P0.001).And the serum TG and TC levels were significantly decreased(t=4.249,P0.001;t=2.231,P=0.026).But no statistically significant change was found in serum HDL-c and LDL-c levels(P0.05). Conclusion The disease details management for hypertension in community can help blood pressure control for hypertension patients,but also improve blood lipid,especially serum TG and TC.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第4期402-404,共3页 Chinese General Practice
基金 上海市疾病预防控制中心和辉瑞中国公司合作的“上海社区高血压疾病细节管理”项目的资助
关键词 高血压 管理 血压 血脂 Hypertension Management Blood pressure Blood lipid
  • 相关文献

参考文献14

  • 1He J, Gu D, Wu X, et al. Major causes of death among men and women in China [J]. N Engl J Med, 2005, 353:1124 -1134.
  • 2Kearney P, Whelton M, Reynolds K, et al. Global burden of hypertension : analysis of worldwide data [ J ]. Lancet, 2005, 365 ( 9455 ) : 217 - 223.
  • 3Lopez A, Mathers C, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001 : Systematic analysis of population health data [J]. Lancet, 2006, 367 (9524): 1747-1757.
  • 4丁明玉,王菲菲.全血黏度异常状况与高血压、高血脂、高血糖的关系[J].中国医药导报,2009,6(3):133-134. 被引量:22
  • 5黄伟雄.社区综合防治对高血压患者生活质量的影响[J].实用心脑肺血管病杂志,2009,17(8):664-665. 被引量:12
  • 6方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 7Kastarinen M J, Puska PM, Korhonen MH, et al. for LIFEH Study Group. Non-pharmacological Treatment of hypertension in primary health care : a 2 - year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland [ J ]. J Hypertens, 2002, 20 (12): 2505-2512.
  • 8Bakris GL, Tarka EA, Waterhouse B, et al. Cardiovascular risk factors in hypertension : Rationale and design of studies to investigate the effects of controlled - release carvedilol on regression of left ventricular hypertrophy and lipid [J]. Am J Cardiol, 2006, 98 (7A) : 46L-52L.
  • 9Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Multiple risk factor intervention trial research group [J]. Arch Intern Med, 1992, 152 (7): 1490-1500.
  • 10张建英,谷梅华.非诺贝特对高三酰甘油血症患者血压、肱动脉舒张值的影响[J].中西医结合心脑血管病杂志,2008,6(11):1278-1279. 被引量:4

二级参考文献28

  • 1Gorden D O L,佟松.全血粘度与心血管疾病[J].国外医学(生物医学工程分册),1993,16(3):166-168. 被引量:1
  • 2李建丽,李爱民,赵金伟.85例高粘血症的血脂水平观察[J].中国血液流变学杂志,2004,14(3):391-391. 被引量:4
  • 3李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1782
  • 4余桂珍,曾琨,陈慧.社区老年人生活质量调查[J].中华护理杂志,2005,40(9):711-713. 被引量:67
  • 5Bakris GL, Tarka EA, Waterhouse B,et al. Cardiovascular risk factors in hypertension:Rationale and design of studies to investigate the effects of controlled - release carvedilol on regression of left ventricular hypertrophy and lipid profile [J]. Am J Cardiol, 2006. 98(7A): 46L- 52L.
  • 6Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Multiple risk factor intervention trial research group[J]. Arch Intern Med,1992,152(7):1490 - 1500.
  • 7Koh KK, Quon MJ, Han SH, et al. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients[J ]. Circulation, 2004,110 (24) : 3687 - 3692.
  • 8Koh KK, Quon MJ, Han SH, et al. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients[J]. Diabetes Care, 2006, 29 (2): 195-201.
  • 9Celermajer DS, Sorensen KE, Bull C, et al. Endothelium - de pendent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction[J]. J Am Coll Cardiol, 1994, 24(8): 1468-1474.
  • 10Koh KK, Quon MJ, Han SH, et al. Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia[J]. J Am Coll Cardiol, 2005,45 (10) : 1649 - 1653.

共引文献3103

同被引文献108

引证文献15

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部